TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome

by Journe, F, Boufker, H Id, Van Kempen, L, Galibert, M-D, Wiedig, M, Salès, F, Theunis, A, Nonclercq, D, Frau, A, Laurent, G, Awada, A, Ghanem, G
Published 2011

Phase I study of pulsatile 3-day administration of afatinib (BIBW 2992) in combination with docetaxel in advanced solid tumors

by Awada, A. H., Dumez, H., Hendlisz, A., Wolter, P., Besse-Hammer, T., Uttenreuther-Fischer, M., Stopfer, P., Fleischer, F., Piccart, M., Schöffski, P.
Published 2012

Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients

by El Hajj, P, Journe, F, Wiedig, M, Laios, I, Salès, F, Galibert, M-D, Van Kempen, L C, Spatz, A, Badran, B, Larsimont, D, Awada, A, Ghanem, G
Published 2013

Randomized Phase 11 Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatis Triple-Negati...

by Baselga, J., Gomez, P., Greil, R., Braga, S., Climent, M., Wardley, A., Kaufman, B., Stemmer, S., Pego, A., Chan, Arlene, Goeminne, J., Graas, M., Kennedy, J., Ciruelos, E.M., Schneeweiss, A., Zubel, A., Groos, J., Melezinkova, H., Awada, A.
Published 2013

SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma

by El Hajj, P, Gilot, D, Migault, M, Theunis, A, van Kempen, L C, Salés, F, Fayyad-Kazan, H, Badran, B, Larsimont, D, Awada, A, Bachelot, L, Galibert, M-D, Ghanem, G, Journe, F
Published 2015